symbol: MTLF
919.8
Cycle B.N.:
2,022,754
Change:
3.12 %
At:
14:24
True to:
23/09/2021

Company profile

Matricelf is a pioneering biotechnology company developing a platform for autologous matrix and cells implants for a wide range of medical conditions. The company was established in 2019 by Professor Tal Dvir of the Laboratory for Tissue Engineering and Regenerative Medicine from Tel Aviv University. Our patented technology is a product of eight years of research and $12 million in grants.

Download Materials

Investor Presentation - Heb
Investor Presentation - En
Matricelf Q2 financial report
תשקיף

Press Release

Matricelf is happy to announce that it won the Unicorn Battle Cup
July 15, 2021
Today we had the honor to host his excellency, Mohammed Al Khaja, UAE ambassador to Israel
July 7, 2021
Matricelf is happy to announce that Dr. Nicholas Theodore, M.D. is joining our Scientific Advisory Board.
March 1, 2021
Matricelf is happy to announce that Dr. Eckhard von Keutz is joining our Scientific Advisory Board
January 18, 2021
Matricelf is excited to announce that it won the state finals at the Startup World Cup
January 17, 2021
Watch the full interview at i24
January 12, 2021

Events

BIO CEO & Investor conference.
February 10, 2020
Global Startup Competition.
January 7, 2020
ICI 2019.
December 9, 2019
Seed Award.
August 27, 2019